Use of dabigatran etexilate to reduce breast cancer progression.

Use of dabigatran etexilate to reduce breast cancer progression.

Item
http://www.wikidata.org/entity/Q34134496
Platelets, coagulation and fibrinolysis in breast cancer progressionThrombin drives tumorigenesis in colitis-associated colon cancerTissue factor, blood coagulation, and beyond: an overview.Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen.Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients.Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasisTissue factor and cell signalling in cancer progression and thrombosis.Regulating surgical oncotaxis to improve the outcomes in cancer patients.Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis.PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?Murine model of hepatic breast cancerThe discovery of dabigatran etexilate.Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: retrospective analysis of safety profile and effect on blood coagulation.
P2860

Use of dabigatran etexilate to reduce breast cancer progression.

Item
http://www.wikidata.org/entity/Q34134496
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Use of dabigatran etexilate to reduce breast cancer progression.
@ast
Use of dabigatran etexilate to reduce breast cancer progression.
@en
Use of dabigatran etexilate to reduce breast cancer progression.
@nl
type
label
Use of dabigatran etexilate to reduce breast cancer progression.
@ast
Use of dabigatran etexilate to reduce breast cancer progression.
@en
Use of dabigatran etexilate to reduce breast cancer progression.
@nl
prefLabel
Use of dabigatran etexilate to reduce breast cancer progression.
@ast
Use of dabigatran etexilate to reduce breast cancer progression.
@en
Use of dabigatran etexilate to reduce breast cancer progression.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Use of dabigatran etexilate to reduce breast cancer progression.
@en
P2093
P304
P31
P356
P433
P478
P577
P5875
P698